Breaking barriers in cancer treatment: Race Oncology pioneers a new era with bisantrene
Race Oncology (ASX:RAC) has announced positive results in killing cancer cells in combination with the drug bisantrene
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
GFL | Ann: Geneva Finance - NZMDT response | 21/03/24 | 0 | 50 | |||
|
|||||||
GFL | Ann: Public Censure of Geneva Finance Limited | 21/03/24 | 0 | 53 | |||
|
|||||||
GFL | Ann: Geneva Announces Interim Dividend | 18/03/24 | 0 | 59 | |||
|
|||||||
GFL | Ann: Geneva Market Update | 18/03/24 | 0 | 92 | |||
|
|||||||
GFL | Ann: Geneva Appoints Independent Director | 12/02/24 | 0 | 59 | |||
|
|||||||
GFL | Ann: Geneva Confirms Permanent Chief Technology Officer | 24/01/24 | 0 | 55 | |||
|
|||||||
GFL | Ann: Geneva Director Resignation | 18/01/24 | 0 | 56 | |||
|
|||||||
GFL | Ann: Geneva Appoints New Insurance Head of Sales and Marketing | 29/12/23 | 0 | 71 | |||
|
See All Discussions